Why Bunge Global Is Back on Investors’ Radar

Bunge Global (BG) has drawn fresh attention after being added to the Zacks Rank #1 list, following a 12.3% upward revision to current year earnings estimates over the past two months.

This shift in expectations comes just weeks before Bunge Global releases its quarterly results on July 29, 2026. Many investors will watch this update closely given the company’s global agribusiness footprint.

Despite the recent Zacks upgrade, Bunge Global’s share price has eased in the short term, with the stock down 8.78% on a 1 month share price return and 14.12% on a 3 month share price return. However, the year to date share price return of 19.32% and 1 year total shareholder return of 41.29% point to momentum that has been stronger over a longer stretch.

If this kind of earnings driven story has your attention, it could be a good moment to broaden your search using Simply Wall St’s screener for 20 top founder-led companies

With Bunge Global trading at US$110.54 alongside an indicated discount to analyst price targets and intrinsic estimates, the key question is whether the stock is still undervalued or whether the market is already accounting for future growth in the price.

Most Popular Narrative: 22.2% Undervalued

At a last close of $110.54 versus a narrative fair value of $142.00, Bunge Global is framed as undervalued, with that gap tied directly to earnings and cash flow expectations under a 7.108% discount rate.

Organic investments in crush expansions (e.g., Morristown, Destrehan) and value-added product lines (specialty oils, plant-based proteins) are expected to ramp up in late 2024 and beyond, enhancing capacity, shifting product mix toward higher-margin offerings, and supporting long-term net margin expansion.

Want to understand why this narrative supports a higher fair value for Bunge Global? The whole case leans on a specific blend of revenue growth, margin rebuild and future earnings multiples that are more commonly associated with higher growth sectors. Curious which assumptions about sales, profitability and valuation need to line up for $142.00 to make sense?

Result: Fair Value of $142.00 (UNDERVALUED)

However, investors in Bunge Global still need to weigh execution risks around the Viterra integration, as well as ongoing cash flow pressure that could affect liquidity and shareholder returns.

Next Steps

Given the mix of optimism and concern around Bunge Global, it makes sense to move quickly and test the story against the underlying numbers and 3 key rewards and 4 important warning signs

Looking For More Investment Ideas Beyond Bunge Global?

If Bunge Global has sharpened your focus on opportunities, do not stop here. Broaden your watchlist now so you are not late to the next move.

• Spot potential mispricings early by scanning 44 high quality undervalued stocks that pair stronger fundamentals with prices that may not fully reflect them.
• Strengthen your income stream by reviewing 8 dividend fortresses that combine higher yields with resilience in their payout history.
• Dial down portfolio stress by filtering for 71 resilient stocks with low risk scores that score well on balance sheet strength and earnings consistency.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.